Introduction {#sec004}
============

In sub-Saharan Africa (SSA), there are an estimated 926 million people, of which an estimated 74.7 million individuals are hypertensive \[[@pone.0130193.ref001]\]. Detection and management of hypertension in the region remains suboptimal \[[@pone.0130193.ref002]\] so much so that by the year 2025, the number of hypertensive individuals is projected to increase by 68% to 125.5 million individuals \[[@pone.0130193.ref001]\]. While an integral part of optimal management includes addressing patient-level factors such as individual knowledge or awareness of hypertension \[[@pone.0130193.ref003]\], we focus exclusively on health system factors to determine the extent to which actions originating at this level-such access to drugs or health insurance coverage, influence hypertension control \[[@pone.0130193.ref004]\]. Moreover, while the patient-level factors have been explored by other studies \[[@pone.0130193.ref005]--[@pone.0130193.ref008]\], studies examining the health systems factors influencing hypertension awareness, treatment, control, and medication adherence in the region are scare. Also in high/middle income countries, although it has been suggested that health care systems present barriers to optimal hypertension control \[[@pone.0130193.ref009]\], available studies indicated that the narrow health services perspective often used in these countries may not be applicable to sub-Saharan African settings \[[@pone.0130193.ref010],[@pone.0130193.ref011]\]. Thus, there is an urgent need to understand how factors operating at the health system level in SSA influence the quality and use of appropriate strategies focused on prevention and management hypertension.

Globally, the past decade has witnessed recognition of the need to strengthen health systems. From the publication of the World Health Report published in 2000 which focused on improving performance in health systems to the role of systems thinking for health systems strengthening, researchers and health organizations such as the World Health Organization increasingly suggested that effective health systems are a prerequisite for achieving good health outcomes. Recent examples of studies in which researchers explored the influence of health systems on health care in SSA include: health systems strengthening through insurance subsidies in Rwanda \[[@pone.0130193.ref012]\], disease control priorities and health systems performance in South Africa \[[@pone.0130193.ref013]\]; equity in financing and use of health care in Ghana, South Africa and Tanzania \[[@pone.0130193.ref014]\]; health systems effectiveness with the delivery of intermittent preventive treatment with sulphadoxine-pyrimethamine to pregnant women in Mali \[[@pone.0130193.ref015]\]; African leadership for sustainable policy and systems research \[[@pone.0130193.ref016]\]; improving health information systems across five sub-Saharan African countries (Ghana, Mozambique, Rwanda, Tanzania, and Zambia) \[[@pone.0130193.ref017]\], electricity access in healthcare facilities\[[@pone.0130193.ref018]\]; human resources for health \[[@pone.0130193.ref019]\] as well as the deployment of community health workers across rural sub-Saharan Africa\[[@pone.0130193.ref020]\].

One effort to define health systems and related characteristics was carried out by the WHO. In their seminal book entitled "Strengthening Health Systems to Improve Health Outcomes," the World Health Organization \[[@pone.0130193.ref021]\] defined health systems as *'all the organizations*, *people*, *and actions whose primary intent is to promote*, *restore*, *or maintain health through efforts that influence the determinants of health as well as direct health-improving activities*.*'* The WHO \[[@pone.0130193.ref021]\] also suggested that regardless of how they are organized, health systems must carry out basic functions known as the *'six essential building blocks of a health system'* and they include: provide services; develop health workers; provide equitable access to essential medical products, vaccines, and technologies; ensure the use of reliable and timely information on health determinants, health systems performance and status; mobilize and allocate finances; and ensure health system leadership and governance.

However, there are sharp criticisms of the building blocks. Mounier-Jack and colleagues \[[@pone.0130193.ref022]\], highlighted the advantages and limitations of using the building blocks in applied research. The authors concluded that despite its value with creating common language and shared understanding, it falls short with evaluating the impact of specific interventions on health systems \[[@pone.0130193.ref022]\]. Similarly, Frenk \[[@pone.0130193.ref023]\] highlighted the need to move beyond common generalizations about health systems, including the perspective that all health systems can be *"defined as a mere list of different organizations or persons that participate in producing health services*.*"* Such a definition, he argues, ignores for example, the population which is an essential part of the system \[[@pone.0130193.ref023]\].

Despite these shortcomings, there is a lack of health systems analysis as applied to hypertension in SSA using either the WHO building blocks or any other model. Instead, recommended actions to improve health systems in SSA often include the need to strengthen health financing \[[@pone.0130193.ref024]\] and/or removal of user fees \[[@pone.0130193.ref025],[@pone.0130193.ref026]\]. However, it is unknown whether other factors and not only user fees or adequate financing alone, play a role with facilitating or hampering access to health systems services that are necessary for achieving optimal hypertension control \[[@pone.0130193.ref025],[@pone.0130193.ref026]\]. Given the impact of hypertension, projected to become the most consequential disease burden by 2025 in SSA, the aim of this paper is to critically examine the health systems factors influencing hypertension awareness, treatment, control, and medication adherence in the region.

Methods {#sec005}
=======

Design {#sec006}
------

Using Popay and colleagues \[[@pone.0130193.ref027]\] as a guide, we conducted a narrative synthesis of available papers that examined the health systems factors influencing optimal management of hypertension in SSA. Narrative synthesis refers to '*an approach to the systematic review and synthesis of findings from multiple sources and relies primarily on the use of words and text to summarize and explain the findings of the synthesis'* \[[@pone.0130193.ref027]\]. It is used when statistical meta-analysis or another specialist form of synthesis (such as meta-ethnography for qualitative studies) is not feasible particularly due to extreme heterogeneity in the methodological descriptions of available studies \[[@pone.0130193.ref027]\]. A narrative synthesis was appropriate for this review given an initial scoping exercise that revealed that the literature was too heterogeneous to permit a meta-analysis \[[@pone.0130193.ref004]\].

Data Sources {#sec007}
------------

Searches of articles were conducted on the PUBMED database. The search was conducted for the period from January 2013 to September 2014. We used the search terms (see [Table 1](#pone.0130193.t001){ref-type="table"} and Appendix) "*hypertension*" and "*Sub-Saharan Africa"* or "" or "*blood pressure*" and "*Africa*" in combination with factors we considered as "*elements of the health systems"*" (See [Fig 1](#pone.0130193.g001){ref-type="fig"} and [S1 Research Protocol](#pone.0130193.s002){ref-type="supplementary-material"} for more details). The review methodology was also adapted from other reviews focused on the influence of health systems on hypertension outcomes \[[@pone.0130193.ref004]\] which we defined as hypertension awareness, treatment, medication adherence, and control (the achievement of BP below 140/90mm Hg). We also retrieved articles from the reference lists of available studies.

![Health Systems Schematic Diagram.\
Adapted from \[[@pone.0130193.ref004]\].](pone.0130193.g001){#pone.0130193.g001}
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###### Search Strategy.

![](pone.0130193.t001){#pone.0130193.t001g}

  ----------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Sub-Saharan Africa                                                            Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Congo (Brazzaville), Congo (Democratic Republic), Côte d\'Ivoire, Djibouti, Equatorial Guinea, Eritrea, Ethiopia, Gabon, The Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, Sudan, Swaziland, Tanzania, Togo, Uganda, Western Sahara, Zambia, Zimbabwe
  Hypertension or high blood pressure adapted from \[[@pone.0130193.ref004]\]   Hypertension, hypertension awareness, hypertension treatment, hypertension medication adherence hypertension control, high blood pressure.
  Health systems factors adapted from \[[@pone.0130193.ref004]\]                Health facilities, diagnostic equipment, health care workers, treatment guidelines, health insurance, financing, governance, social capital
  ----------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Developing a narrative synthesis {#sec008}
--------------------------------

We followed the steps delineated by Popay and colleagues\[[@pone.0130193.ref027]\], namely (1) developing (and/or) identifying a theoretical model, (2) developing a preliminary analysis, (3), exploration of relationships in the data, and (4), assessment of the robustness of the synthesis. Rather than developing a theoretical model as outlined Popay \[[@pone.0130193.ref027]\], we built on the schematic model developed by Maimaris et al.\[[@pone.0130193.ref004]\] which consists of four domains relating to key system level inputs that are required for effective management of chronic diseases such a hypertension (See [Fig 1](#pone.0130193.g001){ref-type="fig"}). Specifically, *"the model aims to capture the complex interactions and inter-relationships that exist between the elements within a health system*. *It also highlights the important role that context plays in shaping the relationships between health system inputs and outcomes*, *while recognizing the complex adaptive nature of health systems* \[[@pone.0130193.ref004]\].*"* Preliminary analysis of the available literature consisted of extracting the descriptive characteristics of retrieved articles in a table so as to produce a textual summary of the results. This enabled the exploration of relationships both within and between the studies reviewed as well as quality appraisal of the methodology used in the studies.

Preliminary Synthesis (Inclusion and exclusion criteria) {#sec009}
--------------------------------------------------------

We included studies conducted from 1992 to June 2013 that reported the effects of health systems factors on hypertension control in SSA. The year 1992 was chosen as it was the year the first comprehensive evaluation of hypertension burden was conducted in the region \[[@pone.0130193.ref028]\]. To be included, and using the conceptual model as a guide, studies had to focus on key health system level inputs (See [Fig 1](#pone.0130193.g001){ref-type="fig"}) influencing hypertension management defined as: hypertension awareness, treatment, control, and medication adherence. Studies were included in the review if they met the following criteria; 1) distinctly identifiable study conducted in sub-Saharan Africa; 2) A direct measurement of any hypertension outcomes and aspects of health systems; 3) Studies conducted with a distinct population (patients, health care workers etc), populations on treatment, and /or with specific co-morbidities such as diabetes. All titles and abstracts were initially screened by two authors to determine eligibility. Disagreements were resolved by a third reviewer with expertise in hypertension management and the role of health systems. We excluded review articles, book chapters and dissertations. Also, we did not apply any language restrictions and the abstracts of articles conducted in other languages were initially scanned for relevance and translated to English if matching the inclusion criteria.

Data Extraction and Exploration of the Relationships between and within Studies {#sec010}
-------------------------------------------------------------------------------

Using a standard template, the first author extracted the following information from available studies: (1) publication citation; (2) country where study was conducted and description of study participants; (3) study design; (4) description of hypertension outcome; (5) and aspects of health care system explored. Extracted data was reviewed by the remaining authors for disparities, erroneous and/or inconsistent data. Relationships between and within studies were explored further through thematic analysis to identify emerging themes relative to health systems building blocks and hypertension outcomes.

Quality Appraisal; Assessing the robustness of synthesis {#sec011}
--------------------------------------------------------

The quality of the reviewed papers was assessed by two reviewers (JI and CE) using a checklist adapted from a previously described assessment criteria \[[@pone.0130193.ref029]\]. On the basis of the criteria, each reviewed paper received a quality grade of low, medium, or high, and any disagreement resulted in joint review of the article. The reviewers specifically appraised the data for the following: Question or objective sufficient described?Study design evident and appropriate?For Quantitative Studies-Method of subject/comparison group selection or source of information/input variables described and appropriate? Subject (and comparison group, if applicable) characteristics sufficiently described? For Qualitative Studies-Context of the Study is Clear?For Quantitative Studies-Outcome and (if applicable) exposure measure(s) well defined and robust to measurement / misclassification bias? Means of assessment reported?For Qualitative Studies-Connection to a theoretical framework / wider body of knowledge?Sampling strategy described, relevant and justified? Sample size appropriate?Analytic methods described/justified and appropriate?For Quantitative Studies-Some estimate of variance is reported for the main results? Data analysis clearly described and systematic?For Qualitative Studies- Data analysis clearly described and systematic?Results reported in sufficient detail?Conclusions supported by the results?

Results {#sec012}
=======

PRISMA guidelines were used to guide reporting of the literature reviewed and a flow diagram is shown in [Fig 2](#pone.0130193.g002){ref-type="fig"} (See [S1 PRISMA Checklist](#pone.0130193.s001){ref-type="supplementary-material"} for more detail)**.** Seven hundred and ninety-three articles were screened by title and abstract for inclusion. Out of 793 articles, the full text of 187 articles were obtained and assessed for eligibility. 25 studies met the eligibility criteria for this review. Full details of the included studies, including study design, population, setting, key findings and risk of bias assessment can be found in [Table 2](#pone.0130193.t002){ref-type="table"}. 18 studies were quantitative in nature, four qualitative \[[@pone.0130193.ref030]--[@pone.0130193.ref033]\], and two were mixed-method study \[[@pone.0130193.ref034],[@pone.0130193.ref035]\]. Of the 18 studies, one was a cluster-randomized trial \[[@pone.0130193.ref036]\]; 4 were cohort studies \[[@pone.0130193.ref037]--[@pone.0130193.ref040]\]; one of which was retrospective \[[@pone.0130193.ref039]\] alongside 2 other retrospective studies \[[@pone.0130193.ref041],[@pone.0130193.ref042]\] and one mixed-method retrospective study \[[@pone.0130193.ref035]\]; 10 were cross-sectional studies. Majority of the studies were carried out in South Africa (n = 9) and in Nigeria (n = 8), 4 in Cameroon, while the rest in the Democratic Republic of Congo, Ethiopia, Ghana, and Tanzania. The narrative synthesis identified the following themes ([Table 3](#pone.0130193.t003){ref-type="table"}): 1) how physical resources within and outside the health system influence supportive mechanism for optimal hypertension control; 2) the role of human resources with enabling and/or inhibiting hypertension control goals; 3) the availability and/or use of intellectual resources; and 4) how health systems financing facilitate and/or compromise access to products necessary for optimal hypertension control.

![Flow of information through the different phases of the systematic review.](pone.0130193.g002){#pone.0130193.g002}

10.1371/journal.pone.0130193.t002

###### Summary of Literature Reviewed.
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  Author                     Setting and Sample Size                                                                                                                                                          Study Design                                                   Detailed Hypertension-related Findings
  -------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Hendriks et al. (2014)     Nigeria, community dwelling adults, n = 3,023                                                                                                                                    Cohort (24 month follow up)                                    Hypertension Control: Systolic blood pressure decreased by 10.41 (95% CI, -13.28 to -7.54) mm Hg among patients in the community-based health insurance program (CBHI). Diastolic blood pressure decreased by 4.27 (95% CI, -5.74 to -2.80) mm Hg in the program area
  Peck et al., 2014          Tanzania, n = 335 health care workers                                                                                                                                            Cross-sectional                                                Hypertension Treatment: First-line drugs for hypertension were frequently lacking. Basic diagnostic equipment for hypertension was consistently present in 63--75% of health facilities, but even hospital outpatient departments sometimes did not have essential instruments such as sphygmomanometers.
  Ndou et al., 2013          South Africa, n = 214 patients                                                                                                                                                   Mixed-methods                                                  Hypertension Control by Community Health Workers in 21.4% of Kgatelopele (community-participants) patients (12/56) were controlled at \>40% of health checks in comparison to 13.1% of clinic patients (22/168).
  Ambaw et al., 2012         Ethiopia, n = 384 participants in Addis Abba                                                                                                                                     Cross-sectional                                                Hypertension Treatment: As the distance from the hospital decreased, the adherence to treatment of HTN improved (AOR = 2.02, 95% CI = 1.19, 3.43).
  Ilesanmi et al., 2012      Nigeria, n = 250 rural patients                                                                                                                                                  Cross-sectional                                                Hypertension Treatment: Mean cost of treatment was ₦1440 ± 560 (\$9.6 ± 3.7) with 52.8% spending ≥ 10% of their income on treatment.
  Mbouemboue et al. (2012)   Cameroon, n = 117 hypertensive patients in Adamawa region                                                                                                                        Cross-sectional                                                Hypertension awareness (baseline 1 for low cost of medications); medium cost 0.35 \[0.06--2.07\]; high cost 0.44 \[0.07--2.75\]
  Labhardt et al., 2011      Cameroon, n = 221 patients                                                                                                                                                       RCT                                                            Hypertension Control: Among the 104 hypertensive patients retained at 1 year, 72 (69%) had a BP of 140⁄90 mmHg at the last visit. Overall average systolic BP decreased from 175.8 to 135.6 mmHg (95% CI: 35.0--45.4, P\< 0.001) and diastolic from 100.7 to 80.1 (17.3--23.9; P\<0.001). Financial incentives added relevant costs to the program. The average monthly cost to patients for antihypertensive medication was €1.10 ± 0.9. The average transport cost among these patients was €1 ± 1.
  Osamor et al., 2011        Nigeria, n = 440                                                                                                                                                                 Cross-sectional                                                Medication Compliance: 51% of the subjects reported high compliance with antihypertensive medication. Among respondents with low compliance, they perceived antihypertensive medications to be necessary but indicated that costs of medication among other factors hindered compliance. The medications were expensive compared to income, and some participants could only buy the quantity of medication they could afford instead of the full prescription (for example, two weeks instead of four weeks).
  Parker et al., 2011        South Africa, n = 16 physicians                                                                                                                                                  Cross-sectional                                                Hypertension Treatment: Ten (62.5%) of the doctors surveyed aimed to treat hypertension to target, and recommendations on lifestyle modifications were reportedly poorly done. While 11 (68.8%) of the doctors were aware of the South African hypertension guidelines, were (81.8%) of them were not conversant with the contents thereof. Doctors estimated that only 35% of their patients are treated to target.
  Labhardt et al., 2010      Cameroon, Central region, n = 493 hypertensive patients with at least one documented follow-up visit at a non-physician clinician facility (NPC)                                 Cohort study-before and after intervention, no control group   Hypertension Control: Fall in BP from baseline to follow up. the BP-decrease remained significant: -26.5 mmHg (95%CI: -12.5 to -40.5) for systolic and -17.2 mmHg (95%CI: -7.1 to -27.3) for diastolic BP.
  Kengne et al. 2009         Cameroon, Yaounde (urban) and Bafut (rural), n = 454 patients in a nurse-led protocol                                                                                            Cohort, 24 month follow up                                     Hypertension Control: Between baseline and final visits, systolic and diastolic blood pressures dropped by 11.7 mm Hg (95% confidence interval, 8.9--14.4) and 7.8 (95% confidence interval, 5.9--9.6), respectively (P \< .001).
  Gombet et al., 2009        Congo, n = 197 patients in Brazzaville                                                                                                                                           Cross-sectional Retrospective                                  Hypertension Control: The overall cost of hypertension emergency care ranged from 74.600 to 18.4600 CFA francs (111.90 to 276.90 euros), i.e., a mean per-patient cost of 159.600 +/-44.107 CFA francs (239.40 +/- 66.20 Euros).Most people living in Brazzaville cannot afford hypertensive emergency
  Rayner et al., 2009,       South Africa, n = 451 patients                                                                                                                                                   Cross-sectional                                                Hypertension Control: BP was reduced by 26.4/17.6 mmHg (*p* \< 0.001) in 220 patients with a documented initial BP. Co-morbidities were present in 322 (71.4%) patients and overall, 37.9% had more than one co-morbidity. Lifestyle modification was not uniformly applied, with only 46.1, 59.6 and 56.8% receiving advice about weight loss, exercise and diet, respectively
  Bradley et al., 2007       South Africa, n = 43 community health workers in Khayelithsha                                                                                                                    Qualitative methods                                            Hypertension Awareness: Lack of knowledge about hypertension and it's risk factors among community health workers
  Dennison et al., 2007      South Africa, n = 403 peri-urban blacks                                                                                                                                          Cross-sectional                                                Hypertension Control: No significant effect of provider type on systolic BP control below threshold (\>140 mmHg systolic and \>90 mmHg diastolic BP); Diastolic BP 3.29 mmHg greater in public versus private
  Kagee et al., 2007         South Africa, n = 23 participants from Western Cape.                                                                                                                             Qualitative methods                                            Medication Adherence: Participants noted that financial barriers related to travelling to clinic, missing a day's wage due to clinic visit, and costs of clinic fees and medication influenced adherence to medication. Also, long waiting times at clinic and long travelling distance.
  Thorogood et al., 2007     South Africa, n = 105 participants, Agincourt sub-district                                                                                                                       Mixed-methods                                                  Hypertension Treatment and Control: Clinic nurses discussed problems with the availability of drugs in the clinics. They either had to deny treatment to patients or switch the treatment to another drug, both actions that are likely to reduce adherence to medication. Nurses also said that they were often unable to monitor blood pressure levels in those with hypertension due to lack of equipment in the clinics and many sphygmomanometers were not functioning at all
  Ono et al., 2006           Nigeria, n = 64 patients in southwest region                                                                                                                                     Cohort (3 year follow up)                                      Hypertension Treatment: There was a tendency to place patients on monotherapy or \"no drug treatment\" with successive repeat visits to the clinic, even in cases of uncontrolled systolic blood pressure, as well as declining prescription of moderately aggressive combination therapy as patients revisited the clinic. Isolated systolic hypertension (ISH) patients who received \"no drug treatment\" on occasions after enrollment were either in borderline stage 1 ISH (33.3%) or in stage 1 ISH (66.7%).
  Yusuf et al., 2005         Nigeria, n = 200 patients, in Ibadan                                                                                                                                             Cross-sectional Retrospective                                  Medication Adherence: Patient adherence with therapy was documented as adequate in 77.5% (107) of cohort. Adverse drug reactions were documented, by physicians, in only 10.9% (15) of cohort. There appear to be currently no organized institutional adverse drug reaction monitoring, detection and documentation system in place.
  Buabeng et al., 2004       Ghana, n = 128 patients at the Komfo Anokye Teaching Hospital                                                                                                                    Qualitative methods                                            Medication Adherence: 93% of the interviewed patients did not comply with their medications. 96% of the non-compliant patients cited unaffordable drug prices as the main reason for non-compliance.
  Mendis et al., 2004        Nigeria, n = 1000 hypertensive patients attending. 56 randomly selected primary- (n = 42) and secondary-level (n = 2) health-care and private health-care (n = 12) facilities.   Cross-sectional                                                Hypertension Awareness, Treatment, and Control: Laboratory and other investigations to exclude secondary hypertension or to assess target organ damage were not available in the majority of facilities, particularly in primary care. A considerable knowledge and awareness gap related to hypertension and its complications was found, both among patients and health-care providers. Blood pressure control rates were poor (28% with systolic blood pressure (SBP) \< 140 mmHg and diastolic blood pressure (DBP) \< 90 mmHg\] and drug prescription patterns were not evidence based and cost effective. The majority of patients (73%) in this low socio-economic group (mean monthly income 73 US dollars) had to pay fully, out of their own pocket, for consultations and medications.
  Salako et al., 2003        Nigeria, n = 143 patients,                                                                                                                                                       Cross-sectional                                                Hypertension Treatment and Control: 51 (36%) of the subjects described as being fully controlled on the treatment instituted while 54 (38%) of the subjects were not controlled at all. In about 18% of the patients, the systolic blood pressure alone was controlled while in 8% the diastolic blood pressure alone was controlled. Furthermore, level of blood pressure control in this study is poor suggesting that availability of free drug alone is not enough to improve adherence to antihypertensives.
  Daniels et al., 2000       South Africa, N = 4 community health care centers, 15 physicians and 10 nurses IN Western Cape                                                                                   Qualitative methods                                            Hypertension Treatment: Treatment guidelines were not systematically implemented at local CHCs and individual doctors consulted the guidelines infrequently. Several themes were identified as barriers to the application of the guidelines, including the consultation process by which the guidelines were developed, time constraints, skepticism about durability of the guidelines, conflict with local practices, health system problems, and patient beliefs.
  Steyn et al., 1999         South Africa, n = 202 patients in Cape town                                                                                                                                      Cross-sectional                                                Hypertension Control: 41.6% had a BP above 160/95 mm Hg and only 42.1% had a BP below 140/90 mm Hg. Patients had little knowledge of either the consequences of hypertension or the actions needed to ensure that complications were prevented; 31% suggested home remedies for hypertension. The majority of the patients were satisfied with the service they received, but 47% complained about long waiting times, 37% felt that the doctor did not examine them adequately, and 15.5% reported that insufficient medication was provided when filling prescriptions.
  Olubodun et al., 1995      Nigeria, n = 42 physicians                                                                                                                                                       Cross-sectional                                                Hypertension Control: Over half do not usually measure the blood pressure (BP) of all new patients. A third do not investigate before starting therapy. Over half commence drug therapy with less than three BP readings, while over two thirds do so from appropriate BP levels.

10.1371/journal.pone.0130193.t003

###### Themes generated from reviewed literature.
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  Health Systems Framework   Health Systems Factor being investigated          Number of Studies and Citation                                                                                                                         Settings of Study
  -------------------------- ------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------ -----------------------------------------------
  Physical Resources         Unreliable drug supply                            3 \[[@pone.0130193.ref034],[@pone.0130193.ref043]\]                                                                                                    South Africa, Tanzania
                             Longer waiting times                              2 \[[@pone.0130193.ref033],[@pone.0130193.ref057]\]                                                                                                    South Africa
                             Equipment                                         3 \[[@pone.0130193.ref034],[@pone.0130193.ref043], [@pone.0130193.ref047]\]                                                                            Nigeria, South Africa, Tanzania
                             Poor knowledge/referral/documentation             5 \[[@pone.0130193.ref031], [@pone.0130193.ref041], [@pone.0130193.ref043], [@pone.0130193.ref052], [@pone.0130193.ref058]\]                           Nigeria, South Africa, Tanzania
                             Long traveling distance                           2 \[[@pone.0130193.ref033], [@pone.0130193.ref044]\]                                                                                                   Ethiopia, South Africa
  Human Resources            Task-shifting to non-physician clinicians         4 \[[@pone.0130193.ref035], [@pone.0130193.ref036], [@pone.0130193.ref038], [@pone.0130193.ref040]\]                                                   Cameroon, South Africa
                             Physician inertia                                 4 \[35, 39. 45. 46\]                                                                                                                                   Nigeria, South Africa
                             Failure to intensify medication                   1 \[[@pone.0130193.ref039]\]                                                                                                                           Nigeria
  Intellectual Resources     Availability and/or use of treatment guidelines   4 \[[@pone.0130193.ref030], [@pone.0130193.ref041], [@pone.0130193.ref043], [@pone.0130193.ref045]\]                                                   Nigeria, South Africa
  Health Systems Financing   Medication co-payments/cost of clinic visit       6 \[[@pone.0130193.ref032], [@pone.0130193.ref033], [@pone.0130193.ref042], [@pone.0130193.ref048], [@pone.0130193.ref049], [@pone.0130193.ref051]\]   Cameroon, Congo, Ghana, Nigeria, South Africa
                             Health insurance coverage                         1 \[[@pone.0130193.ref033]\]                                                                                                                           South Africa
                             Free anti-hypertensive medications                2 \[[@pone.0130193.ref037], [@pone.0130193.ref050]\]                                                                                                   Nigeria

Physical Resources {#sec013}
------------------

The findings identified how physical resources both within and outside the health care system influenced effective management of hypertension in region \[[@pone.0130193.ref004]\]. The physical resources operating within health systems include; unreliable drug supply, longer waiting times for appointment, the lack of functioning equipment, and poor referral and/or documentation of hypertension management. In Tanzania, Peck and colleagues \[[@pone.0130193.ref043]\] observed that first line drugs for hypertension were lacking and "*even hospital outpatient departments sometimes did not have essential instruments such as sphygmomanometers*.*"* In the Agincourt sub-district of South Africa, Thorogood and colleagues \[[@pone.0130193.ref034]\] found that unreliable drug supply were among the barriers influencing the provision of effective treatment for hypertension. Clinic nurses interviewed noted that *"they either had to deny treatment to patients or switch the treatment to another drug*, *actions that are likely to reduce adherence to medication*.*"* The nurses also reported that "*they were unable to monitor blood pressure levels in those with hypertension due to lack of proper equipment in the clinics and/or non-functioning sphygmomanometers*.*"* In Nigeria, Mendis and colleagues (2004) observed that laboratory and other investigations to exclude secondary hypertension or to assess target organ damage were not available in majority of facilities.

Physical resources operating outside the health system include; distance to clinic, particularly long travelling distance. in northwest Ethiopia, longer distance to hospital was found to be significantly associated with adherence to hypertension treatment recommendations with patients from long distant areas less likely to be adherent as compared to patients who resided closer to hospitals \[[@pone.0130193.ref044]\]. Finally, participants in a qualitative study in South Africa stated that travelling to the clinic where they received medication was extremely problematic. Coupled with the long travelling distance, absence of public transport and missing a day's wage, was a major impediment to attending clinic visits regularly \[[@pone.0130193.ref033]\].

Human Resources {#sec014}
---------------

The findings on human resources (trained health care workers) and optimal management of hypertension in SSA were mixed. For example, studies have found that task-shifting to non-physician clinicians for integrated management of hypertension is feasible and effective with improving hypertension care in SSA. In a cohort study conducted by Kengne and colleagues \[[@pone.0130193.ref038]\] in rural and urban Cameroon, the authors implemented a nurse-led hypertension management protocol with 454 patients. Between baseline and follow-up, the authors observed that systolic blood pressure and diastolic blood pressure rates dropped by 11.7 mmHg (8.9--14.4) and 7.8mmHg (5.9--9.6) respectively. Similarly, in a study conducted by Ndou and colleagues \[[@pone.0130193.ref035]\], patients receiving home visits from community health care workers were more likely to achieve blood pressure control goals than those receiving usual care for from the clinic.

On the other hand, physician inertia and/or failure to intensive antihypertensive medication are common in the region. In southwestern Nigeria, Ono and colleagues \[[@pone.0130193.ref039]\] observed that physicians increasingly "*placed patients on monotherapy or \"no drug treatment\"*,. *even in cases of uncontrolled systolic blood pressure*.*"* In the Gauteng Province of South Africa, Ndou and colleagues \[[@pone.0130193.ref035]\] observed that insufficient monitoring of patient outcomes by clinical staff hampered efforts to improve the management of hypertension \[[@pone.0130193.ref035]\]. Also in South Africa, among physicians interview by Parker and colleagues \[[@pone.0130193.ref045]\], observed that therapy was not routinely intensified for the majority of patients \[[@pone.0130193.ref045]\]. Similarly, in a cross-sectional study of blood pressure control in 451 hypertensive patients in South Africa, Rayner and Schoeman \[[@pone.0130193.ref046]\] found evidence of physician inertia with 60.6% of high-risk patients not at target and only 46.1%, 59.6% and 56.8% receiving advice about weight loss, exercise and diet, respectively. Moreover, the authors noted that in the patients not at target BP, there was no action plan in 22.9%, despite the fact that physician had self-identified these patients not to be at target and the majority of patients were either on one- or two-drug treatment \[[@pone.0130193.ref046]\].

Intellectual Resources {#sec015}
----------------------

Three studies documented the availability and/or use of intellectual resources such as hypertension treatment guidelines. In South Africa, Daniel and colleagues \[[@pone.0130193.ref030]\], observed ambivalence towards the South African hypertension treatment guidelines noting *"that physicians do not regularly consult the guidelines citing insufficient resources and time*, *overcrowded clinics*, *decreasing staff*, *and few opportunities for continuing medical education (CME)*.*"* Parker and colleagues \[[@pone.0130193.ref045]\] also observed that in South Africa, physicians were not conversant with the contents of the guidelines. In cases of adverse drug reactions, Yusuf and Balogun \[[@pone.0130193.ref041]\] observed that there was no *'institutional system in place to monitor*, *detect and document adverse drug reactions among patients on anti-hypertensive drug therapy*.*'*

Social resources {#sec016}
----------------

No study reported on the impact of social capital on hypertension awareness, treatment and control in SSA.

Health System Financing {#sec017}
-----------------------

The findings on health systems financing which ranged from medication co-payments, costs of clinic visit to health insurance coverage were also mixed. A recent study among 3,023 community dwelling adults by Hendriks and colleagues \[[@pone.0130193.ref037]\] found that among patients in the community-based health insurance coverage program, systolic blood pressure decreased by 10.41mmHg (-13.28 to 7.54) and diastolic blood pressure by 4.27mmHg (-5.74---2.80). Despite these promising findings, health insurance coverage is often not available in many settings in SSA. Mendis and colleagues \[[@pone.0130193.ref047]\] noted that '*the fact that most patients have to pay out of their own pocket for consultation and medications either fully or in part*, *is likely to have a negative impact on long-term management of hypertension*. In a survey of 250 rural patients with primary hypertension in South West Nigeria, Ilesanmi and colleagues \[[@pone.0130193.ref048]\] observed that about half of the patient were spending a tenth or more of their income on health care related expenses. Similarly, in a survey of 440 community residents in southwest Nigeria, participants stated that *"medications were expensive compared to their income and they only bought the quantity of medication they could afford instead of the full prescription (for example*, *two weeks instead of four weeks)"* \[[@pone.0130193.ref049]\]. High costs of medications have been shown to be associated with poor compliance to antihypertensive treatments in Ghana \[[@pone.0130193.ref032]\]. Buabeng and colleagues \[[@pone.0130193.ref032]\] found that in a sample of 128 patients, 93% did not comply with their medications, citing unaffordable drug prices as the main reason for non-compliance. However, one study found that even in cases where people are given access to free antihypertensive medication, hypertension was not controlled in about 38% of participants *"suggesting that availability of free drug alone is not enough to improve adherence to antihypertensives \[[@pone.0130193.ref050]\]."* A recent study conducted in Cameroon examined the association of medication costs with hypertension awareness and did not find one, although the confidence intervals were wide (odds ratio for hypertension awareness for high medication cost versus low medication cost 0.44, 95% CI 0.07--2.75) \[[@pone.0130193.ref051]\].

Governance and Service Delivery {#sec018}
-------------------------------

No study examined health system arrangement and hypertension management relative to governance. But studies on physician inertia, such as the study conducted by Dennison and colleagues \[[@pone.0130193.ref052]\] in South Africa highlighted the influence of service delivery on hypertension management. For example, the authors suggested the following- *"healthcare provider inertia sends a powerful message to patients*, *families*, *and other health care providers that hypertension control is not important*.*"*\[[@pone.0130193.ref052]\]

Discussion {#sec019}
==========

The literature reviewed provides evidence on the health systems factors influencing hypertension awareness, treatment, control, and medication adherence in SSA. The findings showed that physical resources coupled with human and intellectual resources alongside health systems financing act in varying ways to influence optimal hypertension management in the region. Although barriers to optimal hypertension control exists at the level of the patients for example, in relation to knowledge about hypertension and its consequences, over and beyond these patient-level barriers \[[@pone.0130193.ref009],[@pone.0130193.ref053]\], the findings of the literature reviewed suggest that systems level factors in the form of physical, human, intellectual resources and health systems financing enable and/or hinder equitable access to optimal hypertension care. Systems-level barriers such as lack of finances, high costs of drugs, longer waiting times at health systems, limited capacity for adequate diagnosing and prescribing, poor tracing of non-attending patients, and even poor provision of care by healthcare providers themselves also disproportionately limit the capacity of certain countries in SSA to manage and control increasing hypertension rates in the region.

The ability to provide optimal services by health care workers are influenced by increased patient load, overall increase in workload, and shortage of workers \[[@pone.0130193.ref054]\]. One key issue is the brain drain that has plagued SSA for over 20 years \[[@pone.0130193.ref055],[@pone.0130193.ref056]\]. It has led to an acute and chronic shortage of health workers available to implement primary and secondary prevention of hypertension at available health care systems \[[@pone.0130193.ref054]\]. Although the literature reviewed provided information on the current state of knowledge regarding human resource that influence optimal management of hypertension, many gaps in the literature remain. For example, few studies examined the current workload of available health care workers or how their compensation rates may influence their ability to provide quality care for optimal hypertension. Moreover, the lack of available health care workers in most health care settings in SSA calls for new strategies to reduce brain drain. This knowledge base is necessary if reduction in hypertension related morbidity and mortality rate in SSA is to be achieved.

The same is obviously true for financial barriers in the form of high costs of medication for hypertension and overall health systems costs. For optimal control of hypertension to be achieved, considerable investments need to be made to improve access to equitable healthcare services without imposing excessive burden to individuals and households in the region. The availability of anti-hypertensive drugs is crucial for long-term treatment and control of hypertension. But studies also indicate that free antihypertensive medication is not sufficient by itself alone without the provision of other services such as the availability and use of accurate blood pressure monitoring devices or blood pressure treatment guidelines. Overall quality of care including acceptability (shorter waiting times), affordability (health insurance coverage or low clinic costs), accessibility (shorter distance to health care systems) also matters given the potential for low utilization of health care systems for adequate management of hypertension or non-compliance with antihypertensive drug therapy.

Taken together, delineating the health systems factors influencing optimal hypertension control in the region is a necessary first step towards the development and implementation of interventions aimed at mitigating the systems-level barriers to optimal hypertension control. It is also necessary for researchers to accurately capture the complexities inherent in resource-limited health care systems in SSA and how this may have anticipated or unanticipated effects with hypertension awareness, treatment, control, and medication adherence in the region. While the reduction of hypertension in SSA is influenced by multiple factors operating at the health systems level, identifying key leverage points whether at the level of physical, human, intellectual or health systems financing level (instead of targeting only one level), is likely to produce larger and longer lasting effects.

Limitations of research {#sec020}
-----------------------

There are several limitations for the reviewed research. First, it is impossible to assess a direct link between health systems variables and the increasing prevalence of hypertension in the region because most of the available data are cross-sectional in nature. Longitudinal studies are recommended to understand the full impact of health systems on the management and control of hypertension in the region. Another important issue considered is that objectives of the available literature including the sampling methodology used were highly variable which in turn may raise concerns about the quality of the studies or the logic of combining the findings of all the studies reviewed. The use of narrative synthesis instead of a quantitative, meta-analytic review is crucial as it provided the opportunity to use words and text to summarize and explain findings from the literature reviewed thus providing evidence on the health systems factors influencing optimal hypertension in region. Furthermore, given that the findings were synthesized across countries with few countries represented in this review, the potential for regional differences within SSA may exist with health systems factors associated with optimal hypertension control varying significantly both within and between countries. However, this is a first attempt to discuss the context-specific complexities inherent in certain resource-limited health systems in SSA and how these might influence attempts to mitigate the increasing prevalence of hypertension in region. While a key challenge involves developing ways to understand and account for this complexity in a way that makes intervention practice effective, future research with key stakeholders that utilizes systems thinking strategies such as concept mapping for public health research or systems dynamic modelling, will enrich understanding and elucidate the multiple pathways through which health systems influence optimal management and control of hypertension in the region.

Conclusion {#sec021}
==========

This narrative synthesis represents an effort to summarize existing data on the health systems factors that influence optimal hypertension control in SSA. The findings illustrate how physical, human, intellectual resources alongside health systems financing interact to influence optimal management and control of hypertension. While there were several methodological shortcomings identified, given the increasing prevalence of hypertension in SSA, the findings of this review underscore the need for conducting much-needed research as well as developing and implementing new interventions on a topic of vital public health significance to the region. Understanding health systems factors is also relevant for understanding the patient-level and/or provider-level barriers that influence awareness, treatment, control, and medication adherence is the region. Furthermore, while there have been significant research effort to explore patient-level or provider-level factors, the success of new interventions for optimal hypertension control will also rely on an understanding of factors operating at the health systems level. Simply put, research or new interventions to reduce the increasing prevalence of hypertension in the region might be futile if the same vigor is not applied to addressing the health systems factors that influence the burden of hypertension in SSA. Moreover, knowledge of these factors have implications for the design and implementation of cost-effective interventions aimed at achieving optimal hypertension control in the region while facilitating the reduction of hypertension-related morbidity and mortality rates in SSA. This paper serves as a necessary first step towards open discussions on the complexities inherent in resource-limited heath systems in sub-Saharan Africa and how that might influence management and control of the increasing prevalence of hypertension in the region.
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